Launch of the original combined drug – TARZHFORT®

The pharmaceutical company JSC Avexima expanding its portfolio of gynecological products and launching on the Russian market the original combined intravaginal drug TARZHFORT®.

Avexima is both the developer of the drug TARZHFORT® and the holder its marketing authorization*.

* MPI, LP-006231 – 020620, State Register of Medicines (GRLS), June 2020